The Effect of Early Feeding on Initial Glucose Concentrations in Term Newborns

Yin Zhou1, Shasha Bai2, Joshua A Bornhorst3

  • 1Baylor College of Medicine, Houston, TX.

The Journal of Pediatrics
|November 8, 2016
PubMed

Insights

Early feeding in healthy newborns did not increase initial glucose levels. This study found that early feeding, compared to later feeding, was associated with lower initial glucose concentrations in healthy term infants.

Area of Science:

  • Neonatal Medicine
  • Pediatric Endocrinology
  • Clinical Nutrition

Background:

  • Hypoglycemia is a common concern in newborns.
  • Early feeding practices are debated for their impact on neonatal glucose homeostasis.
  • Understanding glucose trends in relation to feeding is crucial for infant care.

Purpose of the Study:

  • To investigate the effect of early feeding on initial plasma glucose concentrations in healthy term newborns.
  • To compare glucose levels in infants fed before versus after their initial glucose screening.

Main Methods:

  • Retrospective observational study at a single academic medical center.
  • Analysis of plasma glucose concentrations in term infants (born 2008) not at risk for hypoglycemia.
  • Multiple linear regression models to compare glucose levels between early and late feeders.

Main Results:

  • Mean age of first feeding was 0.9 hours for early feeders and 3.8 hours for late feeders.
  • Initial glucose concentrations were not higher in early feeders (51.8 ± 11.9 mg/dL) compared to late feeders (55.5 ± 13.3 mg/dL).
  • Linear regression indicated mean initial glucose was 3.61 mg/dL lower in early feeders.

Conclusions:

  • Early feeding in healthy term newborns does not elevate initial glucose concentrations.
  • Findings suggest early feeding may be beneficial or neutral for glucose levels in healthy infants.
  • These observations could inform management strategies for hypoglycemia in at-risk newborns.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.1K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.9K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
308
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
4.9K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.1K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
8.0K